Custom Oligosaccharides Synthesis
Overview
CD BioGlyco has unique technology platforms and powerful analysis tools to provide customers with high-quality custom services to synthesize oligosaccharides. We have confidence to be your essential research assistant in the field of glycobiology.
Key Technologies
Solid-phase synthesis; Stereospecific glycosylation
Synthesis Simplified, Complexity Delivered
In general, carbohydrates can be divided into two categories: monosaccharides and complex carbohydrates. When two or more monosaccharide units are connected through glycosidic bonds, complex carbohydrates are formed. Oligosaccharides are usually polymers of 3 to 10 monosaccharides, which usually exist in the form of glycans: oligosaccharide chains linked to lipids or amino acid side chains in proteins. Oligosaccharides have many functions, including cell recognition and cell binding. These biological processes involving carbohydrates are usually not related to monosaccharides, but the structure of oligosaccharides in glycoconjugates. Therefore, oligosaccharides are becoming more important in the study of biological activity.
However, in experiments, it is almost impossible to completely separate homogeneous glycoform, and the conversion of glycosylation to clinical applications in humans involves systematic studies using homogeneous samples of oligosaccharides and glycoconjugates. In the past two decades, the understanding of glycobiology has made great strides. These advances are partly attributed to the latest developments in oligosaccharides synthesis, mainly the synthesis of human-type sequences to assist biomedical research. Oligosaccharides can be synthesized by chemical, enzymatic or other biological methods. Complex oligosaccharides synthesis requires a combination of multiple disciplines, including practical synthesis methods and effective tools in cell and molecular biology, biochemistry and glycoproteomics.
Fig 1. Example: human milk oligosaccharides basic structures (Plaza-Díaz, J.; et al. 2018)
Discover Our Services
The structural complexity and wide-range variations of glycans and their conjugates represent the main challenges in the synthesis of such biomolecules. To help customers better research oligosaccharides, CD BioGlyco provides two main methods, chemical synthesis and enzymatic synthesis, to obtain homogeneous oligosaccharides and glycoconjugates.
- Chemical synthesis has always been an exploratory research method as this mature discipline can provide access to almost any structure.
- Enzymatic synthesis can be carried out stereo- and regiospecifically without protecting group manipulations. Compared with chemical glycosylation, the reaction conditions of enzyme-catalyzed glycosylation are extremely mild. Usually enzymatic or chemoenzymatic methods are used for process optimization.
| Custom Cyclodextrin Development | High-performance Liquid Chromatography-Charged Aerosol Detection (HPLC-CAD)-based Oligosaccharides Analysis Service |
|---|---|
![]() |
![]() |
| We provide tailored cyclodextrin development for both Pharmaceutical applications and Non-pharmaceutical uses, employing precise chemical modifications, supported by comprehensive Analysis and characterization. | Utilize CAD coupled with HPLC for universal, label-free quantification and purity assessment of diverse oligosaccharides, independent of chromophore presence. |
| Size Exclusion Chromatography (SEC)-based Oligosaccharides Analysis Service | Polysaccharide Fluorescent Labeling Service |
![]() |
![]() |
| Determine molecular weight distribution, purity, and aggregation state of oligosaccharides and glycoconjugates using high-resolution SEC separation. | Enhance detection sensitivity for complex polysaccharides via covalent attachment of fluorescent tags, enabling advanced analysis by HPLC-fluorescence detection (FLD) or capillary electrophoresis-laser-induced fluorescence (CE-LIF), particularly for trace-level samples. |
With a professional synthesis platform, CD BioGlyco provides our clients with scientific assistance custom cyclodextrin development. Particularly, we provide several strategies to prepare cyclodextrins-guest complexes including kneading, grinding, microwave irradiation, supercritical carbon dioxide, co-precipitation, and spray-dried.
Publication Data
DOI.: 10.1038/s41467-020-17778-1
Journal: Nature communications
IF: 14.7
Published: 2020
Results: The authors developed and validated a novel non-enzymatic chemical method called FITDOG to universally cleave diverse polysaccharides into representative oligosaccharides suitable for structural analysis. Recognizing the lack of a universal enzymatic equivalent to trypsin for polysaccharides due to their immense structural complexity and heterogeneity, FITDOG uses iron-catalyzed oxidation (Fe3+/H2O2) under controlled conditions to depolymerize polysaccharides without bias toward specific linkages or structures. The resulting oligosaccharides, typically with degrees of polymerization (DP) of 3-14, retain key structural features of the parent polymer and can be effectively analyzed using liquid chromatography-mass spectrometry (LC-MS) for applications like polysaccharide identification ("oligosaccharide fingerprinting") in complex mixtures (e.g., food, feces) and de novo structural characterization, as demonstrated for various standards and in a study tracking dietary polysaccharide fate in an infant gut microbiome. This method overcomes a major bottleneck in glycobiology by enabling high-sensitivity, high-throughput structural analysis of polysaccharides.
Workflow

Applications
- Designing and synthesizing novel oligosaccharide mimics or derivatives that can act as inhibitors of pathogen adhesion (e.g., bacterial, viral), modulators of immune responses, or anti-cancer agents.
- Using customized glycans to identify and validate new drug targets by probing their interactions with receptors or enzymes involved in disease pathways.
- Designing and synthesizing glycan-functionalized biomaterials to modulate cell adhesion, differentiation, and tissue regeneration, mimicking the extracellular matrix.
Advantages of Us
- Detailed analysis of the synthesized molecules to ensure the high quality of the final product
- Highly integrated approaches can combine chemical and enzymatic methods to quickly assemble oligosaccharides
- Update methods according to international development
- Customized route design
Frequently Asked Questions
Associated Services
CD BioGlyco fully combines chemical synthesis and enzymatic synthesis to provide customers with high-quality synthetic oligosaccharides. The comprehensive post-synthesis analysis experiment provides a sufficient guarantee for customers' products.
Customers can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.
References
- Plaza-Díaz, J.; et al. Human milk oligosaccharides and immune system development. Nutrients. 2018, 10(8): 1038. (Open Access)
- Amicucci, M.J.; et al. A nonenzymatic method for cleaving polysaccharides to yield oligosaccharides for structural analysis. Nature Communications. 2020, 11(1): 3963. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform










